{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:25:56Z","timestamp":1785209156860,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["No. 2022-PUMCH-B-072"],"award-info":[{"award-number":["No. 2022-PUMCH-B-072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00259-025-07339-3","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T21:55:09Z","timestamp":1748210109000},"page":"4882-4892","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Less is more: once vs. multiple radioactive iodine (RAI) therapy in patients with RAI-avid pulmonary micrometastatic differentiated thyroid cancer"],"prefix":"10.1007","volume":"52","author":[{"given":"Cong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Na","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-4728","authenticated-orcid":false,"given":"Yan-Song","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"7339_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Nat Cancer Center. 2024;4:47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Nat Cancer Center"},{"key":"7339_CR2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","volume":"86","author":"EL Mazzaferri","year":"2001","unstructured":"Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","volume":"97","author":"EL Mazzaferri","year":"1994","unstructured":"Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418\u201328.","journal-title":"Am J Med"},{"key":"7339_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1507\/endocrj.EJ22-0463","volume":"70","author":"N Akatani","year":"2023","unstructured":"Akatani N, Wakabayashi H, Kayano D, Inaki A, Takata A, Hiromasa T, et al. Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan. Endocr J. 2023;70:315\u201322. https:\/\/doi.org\/10.1507\/endocrj.EJ22-0463.","journal-title":"Endocr J"},{"key":"7339_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jncc.2024.06.005","volume":"4","author":"H Zeng","year":"2024","unstructured":"Zeng H, Zheng R, Sun K, Zhou M, Wang S, Li L, et al. Cancer survival statistics in China 2019\u20132021: a multicenter, population-based study. J Nat Cancer Center. 2024;4:203\u201313. https:\/\/doi.org\/10.1016\/j.jncc.2024.06.005.","journal-title":"J Nat Cancer Center"},{"key":"7339_CR6","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Populations - Total U.S. (2014\u20132020), National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, released April 2023. http:\/\/seer.cancer.gov\/statfacts\/html\/thyro.html. Accessed 10 May 2024."},{"key":"7339_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/cen.13489","volume":"88","author":"SY Sohn","year":"2018","unstructured":"Sohn SY, Kim HI, Kim YN, Kim TH, Kim SW, Chung JH. Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up. Clin Endocrinol (Oxf). 2018;88:318\u201326. https:\/\/doi.org\/10.1111\/cen.13489.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7339_CR8","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/cncr.22956","volume":"110","author":"E Sampson","year":"2007","unstructured":"Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007;110:1451\u20136.","journal-title":"Cancer"},{"key":"7339_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/cen.14700","volume":"97","author":"J Maciel","year":"2022","unstructured":"Maciel J, Cavaco D, Silvestre C, Sim\u00f5es Pereira J, Vilar H, Leite V. Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma. Clin Endocrinol (Oxf). 2022;97:814\u201321. https:\/\/doi.org\/10.1111\/cen.14700.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7339_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/EJE-15-0296","volume":"173","author":"H-J Song","year":"2015","unstructured":"Song H-J, Qiu Z-L, Shen C-T, Wei W-J, Luo Q-Y. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. Eur J Endocrinol. 2015;173:399\u2013408. https:\/\/doi.org\/10.1530\/EJE-15-0296.","journal-title":"Eur J Endocrinol"},{"key":"7339_CR11","first-page":"714","volume":"75","author":"NA Samaan","year":"1992","unstructured":"Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR12","first-page":"598","volume":"37","author":"M Schlumberger","year":"1996","unstructured":"Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med. 1996;37:598\u2013605.","journal-title":"J Nucl Med"},{"key":"7339_CR13","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1089\/thy.2006.16.1229","volume":"16","author":"J Jonklaas","year":"2006","unstructured":"Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 2006;16:1229\u201342.","journal-title":"Thyroid"},{"key":"7339_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s00268-005-0472-4","volume":"30","author":"CA Benbassat","year":"2006","unstructured":"Benbassat CA, Mechlis-Frish S, Hirsch D. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer. World J Surg. 2006;30:1088\u201395.","journal-title":"World J Surg"},{"key":"7339_CR15","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1210\/JC.2015-1346","volume":"100","author":"AA Carhill","year":"2015","unstructured":"Carhill AA, Litofsky DR, Ross DS, Jonklaas J, Cooper DS, Brierley JD, et al. Long-term outcomes following therapy in differentiated thyroid carcinoma: NTCTCS registry analysis 1987\u20132012. J Clin Endocrinol Metab. 2015;100:3270\u20139. https:\/\/doi.org\/10.1210\/JC.2015-1346.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1210\/clinem\/dgac600","volume":"108","author":"T Tian","year":"2023","unstructured":"Tian T, Huang S, Dai H, Qi M, Liu B, Huang R. Radioactive iodine-refractory pulmonary metastases of papillary thyroid cancer in children, adolescents, and young adults. J Clin Endocrinol Metab. 2023;108:306\u201314. https:\/\/doi.org\/10.1210\/clinem\/dgac600.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR17","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7339_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"key":"7339_CR19","unstructured":"National Comprehensive Cancer Network. Thyroid Cancer (Version 3.2022). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/thyroid_harmonized-africa.pdf. Accessed 10 Jul 2024."},{"key":"7339_CR20","doi-asserted-by":"publisher","first-page":"E829","DOI":"10.1210\/jc.2012-3933","volume":"98","author":"MM Sabra","year":"2013","unstructured":"Sabra MM, Dominguez JM, Grewal RK, Larson SM, Ghossein RA, Tuttle RM, et al. Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. J Clin Endocrinol Metab. 2013;98:E829\u201336. https:\/\/doi.org\/10.1210\/jc.2012-3933.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1089\/thy.2011.0429","volume":"22","author":"MM Sabra","year":"2012","unstructured":"Sabra MM, Grewal RK, Tala H, Larson SM, Tuttle RM. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans. Thyroid. 2012;22:877\u201383. https:\/\/doi.org\/10.1089\/thy.2011.0429.","journal-title":"Thyroid"},{"key":"7339_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00259-016-3485-3","volume":"44","author":"A Sabet","year":"2017","unstructured":"Sabet A, Binse I, Dogan S, Koch A, Rosenbaum-Krumme SJ, Biersack H-J, et al. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2017;44:190\u20135. https:\/\/doi.org\/10.1007\/s00259-016-3485-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7339_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1210\/jc.2018-01383","volume":"104","author":"G Sapuppo","year":"2019","unstructured":"Sapuppo G, Tavarelli M, Belfiore A, Vigneri R, Pellegriti G. Time to separate persistent from recurrent differentiated thyroid cancer: different conditions with different outcomes. J Clin Endocrinol Metab. 2019;104:258\u201365. https:\/\/doi.org\/10.1210\/jc.2018-01383.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.surg.2017.05.028","volume":"163","author":"MF Bates","year":"2018","unstructured":"Bates MF, Lamas MR, Randle RW, Long KL, Pitt SC, Schneider DF, et al. Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease? Surgery. 2018;163:118\u201323. https:\/\/doi.org\/10.1016\/j.surg.2017.05.028.","journal-title":"Surgery"},{"key":"7339_CR25","unstructured":"Chinese Anti-Cancer Association (CACA) Guidelines for Holistic Integrative Management of Thyroid Cancer [M]. Tianjin: Tianjin Science and Technology Press, 2025;595\u2013675."},{"key":"7339_CR26","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252\u20139.","journal-title":"Clin Cancer Res"},{"key":"7339_CR27","first-page":"2041","volume":"80","author":"SF Dinneen","year":"1995","unstructured":"Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab. 1995;80:2041\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0272989X09341755","volume":"29","author":"PC Austin","year":"2009","unstructured":"Austin PC. The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making. 2009;29:661\u201377. https:\/\/doi.org\/10.1177\/0272989X09341755.","journal-title":"Med Decis Making"},{"key":"7339_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399\u2013424.","journal-title":"Multivariate Behav Res"},{"key":"7339_CR30","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1089\/thy.1998.8.737","volume":"8","author":"DS Cooper","year":"1998","unstructured":"Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the national thyroid cancer treatment cooperative registry. Thyroid. 1998;8:737\u201344.","journal-title":"Thyroid"},{"key":"7339_CR31","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1210\/jc.2012-1083","volume":"97","author":"DSA McLeod","year":"2012","unstructured":"McLeod DSA, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, Ding EL. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab. 2012;97:2682\u201392. https:\/\/doi.org\/10.1210\/jc.2012-1083.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR32","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1007\/s00259-014-2851-2","volume":"41","author":"E-D Thies","year":"2014","unstructured":"Thies E-D, Tanase K, Maeder U, Luster M, Buck AK, H\u00e4nscheid H, et al. The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2014;41:2281\u201390. https:\/\/doi.org\/10.1007\/s00259-014-2851-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7339_CR33","first-page":"1531","volume":"39","author":"AM Samuel","year":"1998","unstructured":"Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med. 1998;39:1531\u20136.","journal-title":"J Nucl Med"},{"key":"7339_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.clon.2017.01.002","volume":"29","author":"F Sun","year":"2017","unstructured":"Sun F, Gerrard GE, Roberts JK, Telford T, Namini S, Waller M, et al. Ten year experience of radioiodine dosimetry: is it useful in the management of metastatic differentiated thyroid cancer? Clin Oncol (R Coll Radiol). 2017;29:310\u20135. https:\/\/doi.org\/10.1016\/j.clon.2017.01.002.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"7339_CR35","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1200\/JCO.2017.75.0232","volume":"36","author":"RJ Molenaar","year":"2018","unstructured":"Molenaar RJ, Sidana S, Radivoyevitch T, Advani AS, Gerds AT, Carraway HE, et al. Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer. J Clin Oncol. 2018;36:1831\u20139. https:\/\/doi.org\/10.1200\/JCO.2017.75.0232.","journal-title":"J Clin Oncol"},{"key":"7339_CR36","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1200\/JCO.21.01841","volume":"40","author":"E Pasqual","year":"2022","unstructured":"Pasqual E, Schonfeld S, Morton LM, Villoing D, Lee C, de Berrington Gonzalez A, et al. Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies. J Clin Oncol. 2022;40:1439\u201349. https:\/\/doi.org\/10.1200\/JCO.21.01841.","journal-title":"J Clin Oncol"},{"key":"7339_CR37","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2010.0178","volume":"20","author":"RM Tuttle","year":"2010","unstructured":"Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010;20:1341\u20139. https:\/\/doi.org\/10.1089\/thy.2010.0178.","journal-title":"Thyroid"},{"key":"7339_CR38","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/thy.2009.0133","volume":"19","author":"J-D Lin","year":"2009","unstructured":"Lin J-D, Hsueh C, Chao T-C. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome. Thyroid. 2009;19:1053\u20139. https:\/\/doi.org\/10.1089\/thy.2009.0133.","journal-title":"Thyroid"},{"key":"7339_CR39","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1210\/clinem\/dgad697","volume":"109","author":"Z Mu","year":"2024","unstructured":"Mu Z, Zhang X, Sun D, Sun Y, Shi C, Ju G, et al. Characterizing genetic alterations related to radioiodine avidity in metastatic thyroid cancer. J Clin Endocrinol Metab. 2024;109:1231\u201340. https:\/\/doi.org\/10.1210\/clinem\/dgad697.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1210\/jc.2012-2458","volume":"98","author":"FA Verburg","year":"2013","unstructured":"Verburg FA, M\u00e4der U, Tanase K, Thies E-D, Diessl S, Buck AK, et al. Life expectancy is reduced in differentiated thyroid cancer patients \u2265 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab. 2013;98:172\u201380. https:\/\/doi.org\/10.1210\/jc.2012-2458.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR41","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1089\/thy.2015.0395","volume":"26","author":"MM Sabra","year":"2016","unstructured":"Sabra MM, Ghossein R, Tuttle RM. Time course and predictors of structural disease progression in pulmonary metastases arising from follicular cell-derived thyroid cancer. Thyroid. 2016;26:518\u201324. https:\/\/doi.org\/10.1089\/thy.2015.0395.","journal-title":"Thyroid"},{"key":"7339_CR42","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","volume":"366","author":"M Schlumberger","year":"2012","unstructured":"Schlumberger M, Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med. 2012;366:1663\u201373. https:\/\/doi.org\/10.1056\/NEJMoa1108586.","journal-title":"N Engl J Med"},{"key":"7339_CR43","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMe1202172","volume":"366","author":"EK Alexander","year":"2012","unstructured":"Alexander EK, Larsen PR. Radioiodine for thyroid cancer\u2013is less more? N Engl J Med. 2012;366:1732\u20133. https:\/\/doi.org\/10.1056\/NEJMe1202172.","journal-title":"N Engl J Med"},{"key":"7339_CR44","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1210\/clinem\/dgac745","volume":"108","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu J-R, Mu Z-Z, Cheng X-Q, Lin Y-S. Response to surgery assessments for sparing radioiodine remnant ablation in intermediate-risk papillary thyroid cancer. J Clin Endocrinol Metab. 2023;108:1330\u20137. https:\/\/doi.org\/10.1210\/clinem\/dgac745.","journal-title":"J Clin Endocrinol Metab"},{"key":"7339_CR45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa2111953","volume":"386","author":"S Leboulleux","year":"2022","unstructured":"Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, Al Ghuzlan A, Catargi B, et al. Thyroidectomy without radioiodine in patients with low-risk thyroid cancer. N Engl J Med. 2022;386:923\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2111953.","journal-title":"N Engl J Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07339-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07339-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07339-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:32:01Z","timestamp":1762327921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07339-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":45,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["7339"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07339-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Hospital Ethics Committee of Peking Union Medical College Hospital (JS-2432).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The manuscript has never been published elsewhere and the authors have nothing to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}